Filing Details
- Accession Number:
- 0001209191-23-043165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-21 20:52:50
- Reporting Period:
- 2023-07-19
- Accepted Time:
- 2023-07-21 20:52:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1863127 | Tyra Biosciences Inc. | TYRA | Pharmaceutical Preparations (2834) | 831476348 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1880946 | Daniel Bensen | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-19 | 207 | $0.61 | 528,188 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-07-19 | 207 | $16.08 | 527,981 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-07-21 | 3,900 | $0.61 | 531,881 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-07-21 | 3,900 | $16.01 | 527,981 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-19 | 207 | $0.00 | 207 | $0.61 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-21 | 3,900 | $0.00 | 3,900 | $0.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 137,403 | 2030-01-26 | No | 4 | M | Direct | |
| 133,503 | 2030-01-26 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.
Billionaire Hedge Funds
